Melatonin Protects Intact Rat Ovarian Transplantation via the MT1/Nrf2/ARE Pathway

Lingyun Xie1, Shanshan Wang1, Yuling Wu1

  • 1Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai 200433, China.

Cells
|October 28, 2025
PubMed

Insights

Melatonin protects cryopreserved transplanted ovaries from damage by reducing oxidative stress and inflammation. This fertility restoration approach preserves ovarian function via the MT1/Nrf2/ARE pathway.

Area of Science:

  • Reproductive biology
  • Pharmacology
  • Cellular and molecular medicine

Background:

  • Ovarian cryopreservation and transplantation offer fertility restoration for cancer patients.
  • Ischemia-reperfusion injury significantly compromises ovarian graft function post-transplantation.

Purpose of the Study:

  • To evaluate melatonin's protective effects on cryopreserved transplanted ovaries.
  • To elucidate the antioxidant and anti-inflammatory mechanisms of melatonin, focusing on the Nrf2/ARE pathway.

Main Methods:

  • Intact rat ovaries were cryopreserved, transplanted, and treated with melatonin (25 and 50 mg/kg).
  • Assessed estrous cycle recovery, ovarian histology, hormone levels, oxidative stress markers, and inflammatory cytokines.
  • Investigated the MT1/Nrf2/ARE signaling pathway using receptor antagonists and Nrf2 inhibitors.

Main Results:

  • High-dose melatonin (50 mg/kg) accelerated estrous cycle recovery and improved ovarian histology.
  • Melatonin enhanced antioxidant capacity and reduced inflammatory cytokines in serum and ovarian tissue.
  • Melatonin's protective effects were mediated by the MT1 receptor activating the Nrf2/ARE pathway, confirmed by antagonist and inhibitor studies.

Conclusions:

  • Melatonin effectively mitigates ischemia-reperfusion injury in transplanted ovaries.
  • The MT1/Nrf2/ARE signaling axis is crucial for melatonin's antioxidant and anti-inflammatory actions in ovarian grafts.
  • Melatonin preserves ovarian function post-transplantation, offering a potential therapeutic strategy for fertility preservation.